SCHEMBL19831560

SCHEMBL19831560

C#C/C=C\C(=C/C)c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 5/20 0.33
▸ MAOA P21397 4/20 0.33
▸ RECQL P46063 2/20 0.32
▸ ATM Q13315 1/20 0.32
▸ MAPT P10636 3/20 0.31
▸ POLB P06746 1/20 0.31
▸ PLIN1 O60240 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ BCHE P06276 1/20 0.31
▸ TNFRSF1A P19438 1/20 0.31
▸ ACHE P22303 1/20 0.31
▸ PLIN5 Q00G26 1/20 0.31
▸ CYP1B1 Q16678 1/20 0.31
▸ ABHD5 Q8WTS1 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.30
▸ CES2 O00748 2/20 0.30
▸ CES1 P23141 2/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ HDAC3 O15379 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26437500 0.89 SMN1; SMN2 (0.40) MAPTPOLBLMNACYP1B1ALDH1A1
SCHEMBL18460837 0.76 ATM (0.38) MAOBRECQLATMMAPTPLIN1
SCHEMBL28085607 0.76 ATM (0.38) MAOBRECQLATMMAPTPLIN1
SCHEMBL22458171 0.75 PTPN5 (0.38) —
SCHEMBL1072240 0.73 CES2 (0.38) RECQLATMMAPTPOLBALDH1A1
SCHEMBL1072242 0.73 CES2 (0.38) RECQLATMMAPTPOLBALDH1A1
SCHEMBL18929539 0.73 ATM (0.34) MAOBMAOARECQLATMPOLB
SCHEMBL24884751 0.72 ATM (0.35) MAOBMAOARECQLATMMAPT
SCHEMBL20616726 0.72 MEN1 (0.42) MAOBMAOAMAPTALDH1A1MAPK1
SCHEMBL24726973 0.72 KDM4E (0.45) ATMMAPTALDH1A1HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180028507-A1 3-CARBAMOYLPHENYL-4-CARBOXAMIDE AND ISOPHTALAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-02-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180028507-A1 3-CARBAMOYLPHENYL-4-CARBOXAMIDE AND ISOPHTALAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY WNT1, WNT3A, WNT3 MAOB 2937/4885MAOA 3519/4885RECQL 2682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback